ArticleBrazilian journal of otorhinolaryngology
Analysis of neonatal hearing screening coverage by State in Brazil.
Article in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAnalyze the evolution of Neonatal Hearing Screening coverage in Brazil, by region and state, over the 12-years following the publication of the Neonatal Hearing Screening Care Guidelines in 2012, aiming to identify trends and the current situation.
methodsThe study was based on national data from public health care system notifications collected between 2012 and 2023. Segmental regression models were applied to identify changes in temporal trends.
resultsNeonatal Hearing Screening coverage increased from 25.93% in 2012 to 34.43% in 2018 but dropped to 26.39% in 2023. Paradoxically proportion of screenings conducted with Brainstem Auditory Evoked Potential doubled from 2012 to 2023. The South region had the highest average coverage (62.52%), while the North region showed the lowest performance (11.91%). The highest rate in 2023 were 83.19% in the Federal District. These results are limited by the secondary data source from public health and may be affected by underreporting and exclusion of private sector.
conclusionNeonatal Hearing Screening coverage in Brazil remains critically unsatisfactory and falls short of the 95% target. The significant decline after 2018 calls for detailed investigation and urgent intervention to reverse this trend. LEVEL OF EVIDENCE: 4 - Cross-sectional study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.